Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 13 | 2024 | 2002 | 2.060 |
Why?
|
Calcinosis | 12 | 2024 | 1467 | 2.060 |
Why?
|
Aortic Valve | 14 | 2024 | 1950 | 2.020 |
Why?
|
Heart Valve Diseases | 5 | 2024 | 1033 | 0.740 |
Why?
|
Natriuretic Peptide, C-Type | 2 | 2017 | 18 | 0.710 |
Why?
|
Atherosclerosis | 5 | 2024 | 3401 | 0.700 |
Why?
|
Receptors, Atrial Natriuretic Factor | 2 | 2017 | 43 | 0.630 |
Why?
|
Osteogenesis | 4 | 2022 | 1271 | 0.600 |
Why?
|
Cell-Derived Microparticles | 1 | 2019 | 161 | 0.570 |
Why?
|
MicroRNAs | 3 | 2024 | 3783 | 0.570 |
Why?
|
Arteries | 3 | 2020 | 1125 | 0.540 |
Why?
|
Exosomes | 1 | 2019 | 423 | 0.460 |
Why?
|
Aortic Aneurysm | 1 | 2017 | 648 | 0.420 |
Why?
|
Proteomics | 7 | 2024 | 3816 | 0.360 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2021 | 2115 | 0.360 |
Why?
|
Computational Biology | 2 | 2022 | 3502 | 0.340 |
Why?
|
Cells, Cultured | 10 | 2024 | 18940 | 0.240 |
Why?
|
Polycarboxylate Cement | 1 | 2024 | 18 | 0.230 |
Why?
|
Drug Discovery | 2 | 2021 | 1044 | 0.210 |
Why?
|
Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
Heart Valve Prosthesis | 2 | 2024 | 1466 | 0.190 |
Why?
|
Myofibroblasts | 3 | 2017 | 207 | 0.180 |
Why?
|
Medical Illustration | 1 | 2021 | 135 | 0.180 |
Why?
|
Calgranulin B | 1 | 2020 | 86 | 0.170 |
Why?
|
Apolipoprotein C-III | 1 | 2021 | 208 | 0.170 |
Why?
|
Receptors, LDL | 2 | 2019 | 485 | 0.160 |
Why?
|
Collagen Type I | 1 | 2022 | 616 | 0.160 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 580 | 0.150 |
Why?
|
Protein Precursors | 1 | 2022 | 1133 | 0.150 |
Why?
|
Cyclic GMP | 1 | 2017 | 395 | 0.140 |
Why?
|
Fluorine Radioisotopes | 1 | 2019 | 413 | 0.130 |
Why?
|
Genomics | 2 | 2021 | 5790 | 0.120 |
Why?
|
Proteoglycans | 1 | 2017 | 801 | 0.120 |
Why?
|
Mitral Valve Insufficiency | 1 | 2024 | 1401 | 0.120 |
Why?
|
Heart Valves | 1 | 2015 | 284 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1317 | 0.110 |
Why?
|
Extracellular Matrix | 2 | 2017 | 1723 | 0.110 |
Why?
|
Hyperlipidemias | 1 | 2017 | 772 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 872 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1186 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1629 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2015 | 591 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 2 | 2020 | 1505 | 0.090 |
Why?
|
Genitalia, Female | 1 | 2011 | 147 | 0.090 |
Why?
|
Aorta | 1 | 2017 | 2037 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1740 | 0.080 |
Why?
|
Penis | 1 | 2010 | 213 | 0.080 |
Why?
|
Collagen | 1 | 2017 | 2635 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2634 | 0.080 |
Why?
|
Animals | 13 | 2023 | 167768 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7583 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4549 | 0.080 |
Why?
|
Swine | 1 | 2017 | 5892 | 0.070 |
Why?
|
Humans | 19 | 2024 | 758406 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3754 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 2010 | 451 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14354 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2015 | 1870 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11892 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5737 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13468 | 0.060 |
Why?
|
Fibrosis | 2 | 2023 | 2038 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16534 | 0.050 |
Why?
|
Proteome | 2 | 2024 | 1855 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9404 | 0.050 |
Why?
|
Signal Transduction | 3 | 2020 | 23342 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2016 | 0.050 |
Why?
|
Apomorphine | 2 | 2011 | 149 | 0.050 |
Why?
|
Rheumatic Heart Disease | 1 | 2022 | 165 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 294 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1097 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6362 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2023 | 479 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4429 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 353 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2022 | 823 | 0.040 |
Why?
|
Mice | 3 | 2023 | 81101 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
Water | 1 | 2024 | 1402 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 552 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11593 | 0.030 |
Why?
|
Polymers | 1 | 2024 | 1616 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2018 | 550 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1651 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3069 | 0.030 |
Why?
|
Nanofibers | 1 | 2015 | 66 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1355 | 0.030 |
Why?
|
Aging | 2 | 2011 | 8650 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1788 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1826 | 0.030 |
Why?
|
Porosity | 1 | 2015 | 349 | 0.030 |
Why?
|
Rabbits | 1 | 2021 | 4772 | 0.030 |
Why?
|
Bioreactors | 1 | 2015 | 244 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2020 | 1111 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2019 | 815 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5410 | 0.020 |
Why?
|
Clitoris | 1 | 2011 | 35 | 0.020 |
Why?
|
Vulva | 1 | 2011 | 82 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2011 | 151 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2011 | 186 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3533 | 0.020 |
Why?
|
Hydrochlorothiazide | 1 | 2011 | 94 | 0.020 |
Why?
|
Hypertension | 1 | 2011 | 8499 | 0.020 |
Why?
|
Rats | 3 | 2011 | 23679 | 0.020 |
Why?
|
Penile Erection | 1 | 2010 | 100 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13447 | 0.020 |
Why?
|
Hydrogels | 1 | 2015 | 723 | 0.020 |
Why?
|
Phenylephrine | 1 | 2010 | 293 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2011 | 8143 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2011 | 1317 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 428 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9311 | 0.020 |
Why?
|
Enalapril | 1 | 2011 | 311 | 0.020 |
Why?
|
Proteins | 1 | 2024 | 6026 | 0.020 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 926 | 0.020 |
Why?
|
Simvastatin | 1 | 2011 | 351 | 0.020 |
Why?
|
Acetylcholine | 1 | 2010 | 628 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1486 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3584 | 0.020 |
Why?
|
Pelvis | 1 | 2011 | 743 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2015 | 11471 | 0.020 |
Why?
|
Vagina | 1 | 2011 | 838 | 0.020 |
Why?
|
Osteoblasts | 1 | 2011 | 1142 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9460 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2239 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15225 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3432 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22003 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 73809 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10718 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22029 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15785 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18119 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3227 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10416 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18358 | 0.010 |
Why?
|
Male | 2 | 2011 | 358747 | 0.000 |
Why?
|
Female | 1 | 2011 | 390323 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(58)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_